Mirum Pharmaceuticals, Inc. (MIRM) Earnings
|
Expand Research on MIRM
| Next EPS Date | 7/31/26 *Est. | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -79.1% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +4.5% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
4/30/26  |
Q126 | N/A | -$0.34 | N/A | N/A | $147.88M | N/A | N/A | N/A | ||
| 2/25/26 |
Q425 | N/A | -$0.02 | N/A | N/A | $138.89M | = | N/A | N/A | ||
| 11/4/25 | Q325 | $0.05 | -$0.15 | +$0.20 | $133.01M | $130.11M | = |  | | Details | |
| 8/6/25 | Q225 | -$0.12 | -$0.33 | +$0.21 | $127.78M | $107.36M | = | | | Details | |
| 7/31/25 |
Q225 | N/A | -$0.33 | N/A | N/A | $107.36M | = | N/A | N/A | ||
| 5/7/25 | Q125 | -$0.30 | -$0.31 | +$0.01 | $111.6M | $98.02M | = | | | Details | |
| 5/1/25 |
Q125 | N/A | -$0.31 | N/A | N/A | $98.02M | = | N/A | N/A | ||
| 2/26/25 | Q424 | -$1.85 | -$0.30 | -$1.55 | $99.41M | $95.4M | = | | | Details |
